Age-wise Examination of the Association of Obesity Based on Body Mass Index and Waist Circumference with Metabolic Diseases in Comprehensive Health Checkup Participants

Overview

Journal Obes Sci Pract

Date 2024 Mar 19

PMID 38501152

Authors

Yuiko Yamamoto

Kentaro Ikeue

Megumi Kanasaki

Hajime Yamakage

Noriko Satoh-Asahara

Izuru Masuda

Kojiro Ishii

Affiliations

Soon will be listed here.

Abstract

Aim: Body mass index and waist circumference are used for obesity diagnosis and screening of visceral fat; however, their evidence in older adults is insufficient. This study investigated the age-specific association of body mass index and waist circumference with metabolic diseases, assessing their applicability as diagnostic criteria for individuals aged ≥65 years.

Methods: Analysis included 46,324 individuals aged ≥18 years, categorized into five age groups: 18-44, 45-54, 55-64, 65-74, and ≥75 years. Logistic regression analyses identified associations between obesity and metabolic diseases, stratified by age and sex.

Results: Men with obesity based on body mass index had a significantly high risk of hypertension, diabetes mellitus, and dyslipidemia across all age groups (all, < 0.05). Obesity based on waist circumference was significantly positively associated with all metabolic diseases (all, < 0.05). Women with obesity based on body mass index and waist circumference had a significantly high risk of all metabolic diseases across all age groups (all, < 0.05), except for diabetes mellitus in individuals aged ≥75 years.

Conclusions: Participants with obesity based on body mass index and waist circumference exhibited a high risk of hypertension, diabetes mellitus, and dyslipidemia among those aged 18-74 years and men aged ≥75 years. This study contributes to the early prevention and control of metabolic diseases.

Citing Articles

The Frequency and Main Characteristics of Obesity in Undocumented Migrants Receiving Medical Assistance from a Charitable Organisation in Italy.

Franchi M, Fiorini G, Conflitti C, Schibuola F, Rigamonti A, Sartorio A Healthcare (Basel). 2024; 12(23).

PMID: 39684947 PMC: 11641085. DOI: 10.3390/healthcare12232326.

Age-wise examination of the association of obesity based on body mass index and waist circumference with metabolic diseases in comprehensive health checkup participants.

Yamamoto Y, Ikeue K, Kanasaki M, Yamakage H, Satoh-Asahara N, Masuda I Obes Sci Pract. 2024; 10(2):e746.

PMID: 38501152 PMC: 10946448. DOI: 10.1002/osp4.746.

References

Zhou Q, Sun J, Wu Z, Wu W, Zhang X, Pan Q . The older, the less potential benefit for type 2 diabetes from weight control. BMC Geriatr. 2022; 22(1):346. PMC: 9022304. DOI: 10.1186/s12877-022-02979-8. View

Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K . Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017; 17(7):1045-1047. DOI: 10.1111/ggi.13118. View

Westerterp K . Changes in physical activity over the lifespan: impact on body composition and sarcopenic obesity. Obes Rev. 2018; 19 Suppl 1:8-13. DOI: 10.1111/obr.12781. View

Tsai A, Lee S . Determinants of new-onset diabetes in older adults—Results of a national cohort study. Clin Nutr. 2014; 34(5):937-42. DOI: 10.1016/j.clnu.2014.09.021. View

Ohnishi H, Saitoh S, Akasaka H, Mitsumata K, Chiba M, Furugen M . Incidence of hypertension in individuals with abdominal obesity in a rural Japanese population: the Tanno and Sobetsu study. Hypertens Res. 2008; 31(7):1385-90. DOI: 10.1291/hypres.31.1385. View

Shimokata H, Ando F, Yuki A, Otsuka R . Age-related changes in skeletal muscle mass among community-dwelling Japanese: a 12-year longitudinal study. Geriatr Gerontol Int. 2014; 14 Suppl 1:85-92. DOI: 10.1111/ggi.12219. View

Yamada T, Kimura-Koyanagi M, Sakaguchi K, Ogawa W, Tamori Y . Obesity and risk for its comorbidities diabetes, hypertension, and dyslipidemia in Japanese individuals aged 65 years. Sci Rep. 2023; 13(1):2346. PMC: 9911391. DOI: 10.1038/s41598-023-29276-7. View

Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A . Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. J Diabetes Res. 2021; 2021:7796727. PMC: 8516544. DOI: 10.1155/2021/7796727. View

Tokunaga K, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Fujioka S . Ideal body weight estimated from the body mass index with the lowest morbidity. Int J Obes. 1991; 15(1):1-5. View

10.

Onoue H, Koyama T, Zamami Y, Hagiya H, Tatebe Y, Mikami N . Trends in Polypharmacy in Japan: A Nationwide Retrospective Study. J Am Geriatr Soc. 2018; 66(12):2267-2273. DOI: 10.1111/jgs.15569. View

11.

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019; 42(9):1235-1481. DOI: 10.1038/s41440-019-0284-9. View

12.

Park S, Goodpaster B, Lee J, Kuller L, Boudreau R, de Rekeneire N . Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009; 32(11):1993-7. PMC: 2768193. DOI: 10.2337/dc09-0264. View

13.

Konig M, Spira D, Demuth I, Steinhagen-Thiessen E, Norman K . Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2017; 73(1):117-122. DOI: 10.1093/gerona/glx074. View

14.

Wander P, Boyko E, Leonetti D, McNeely M, Kahn S, Fujimoto W . Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. 2012; 36(2):289-93. PMC: 3554282. DOI: 10.2337/dc12-0198. View

15.

Makizako H, Shimada H, Doi T, Tsutsumimoto K, Lee S, Lee S . Age-dependent changes in physical performance and body composition in community-dwelling Japanese older adults. J Cachexia Sarcopenia Muscle. 2017; 8(4):607-614. PMC: 5566639. DOI: 10.1002/jcsm.12197. View

16.

Fukushima M, Suzuki H, Seino Y . Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004; 66 Suppl 1:S37-43. DOI: 10.1016/j.diabres.2003.11.024. View

17.

Mitchell W, Williams J, Atherton P, Larvin M, Lund J, Narici M . Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012; 3:260. PMC: 3429036. DOI: 10.3389/fphys.2012.00260. View

18.

Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H . Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int. 2020; 11(3):165-223. PMC: 7387396. DOI: 10.1007/s13340-020-00439-5. View

19.

Takeda M, Tanaka T, Kudo T . Gender difference in psychogeriatric disorders. Geriatr Gerontol Int. 2011; 11(4):377-82. DOI: 10.1111/j.1447-0594.2011.00736.x. View

20.

Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H . Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2020; 12(1):30-38. PMC: 7890144. DOI: 10.1002/jcsm.12651. View